Related Experiment Video
Updated: Aug 13, 2026
10:08
Flow Cytometry Analysis of Tissue Factor Expression in Human Platelets
Published on: November 22, 2024
Structure, function and biology of tissue factor pathway inhibitor-2
Hitendra S Chand1, Donald C Foster, Walter Kisiel
1Department of Pathology, University of New Mexico Health Sciences Center, Albuquerque, New Mexico, 87131-0001, USA.
Thrombosis and Haemostasis
|January 18, 2006
Summary
Tissue factor pathway inhibitor-2 (TFPI-2) regulates extracellular matrix remodeling. Reduced TFPI-2 synthesis is linked to inflammation, angiogenesis, atherosclerosis, and tumor growth, highlighting its crucial physiological roles.
Area of Science:
- Biochemistry
- Molecular Biology
- Physiology
Background:
- Tissue factor pathway inhibitor-2 (TFPI-2) is a Kunitz-type serine proteinase inhibitor.
- TFPI-2 is associated with the extracellular matrix and regulates matrix digestion and remodeling.
- Reduced TFPI-2 synthesis is implicated in various pathophysiological conditions.
Purpose of the Study:
- To review current information on TFPI-2 expression, inhibitory activity, and specificity.
- To discuss the physiological roles of TFPI-2 based on in-vivo studies.
Main Methods:
- Literature review of studies on TFPI-2 expression in various tissues.
- Analysis of in-vitro data on TFPI-2 inhibitory activity and proteinase specificity.
- Synthesis of in-vivo study findings to infer physiological roles.
Main Results:
- TFPI-2 inhibits a broad spectrum of serine proteinases, primarily via its first Kunitz-type domain.
- TFPI-2 expression is documented across various tissues.
- Reduced TFPI-2 levels correlate with inflammation, angiogenesis, atherosclerosis, retinal degeneration, and tumor growth/metastasis.
Conclusions:
- TFPI-2 is a significant regulator of extracellular matrix digestion and remodeling.
- Dysregulation of TFPI-2 contributes to multiple diseases, underscoring its importance in physiological processes.
Related Concept Videos
01:20Extrinsic and Intrinsic Pathways of Hemostasis
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:18Structure and Function of Platelets
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
01:16Clot Retraction and Fibrinolysis
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
01:24Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
01:16TGF - β Signaling Pathway
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...